Recent research suggests that the common fusion of two genes may point to a molecular basis for prostate cancer.
Optimize Urology Revenue: A Case Study with 20% Faster Accounts Receivable and 8% Higher Collections
How APPs can bridge the gap in urologist shortages
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
The aging surgeon: A geriatrician's perspective
"We all need to revisit meaningful methods for ongoing assurance of competency specific to our fields of medicine and surgery across the physician career span," writes Hal H. Atkinson, MD, MS.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Liposomal tacrolimus shows promise for hemorrhagic cystitis
Liposomal tacrolimus led to improvements in hematuria, bleeding sites on cystoscopy, microscopic urine analysis for red blood cells, and urinary symptoms.
EP. 1B: Overview of Advanced/Metastatic Prostate Cancer
In the first article of this series, Nilay Gandhi, MD, explains the treatment and management of patients with advanced/metastatic prostate cancer and details the options for androgen deprivation therapy.
2 Clarke Drive Cranbury, NJ 08512